Dexus Finance Pty Limited
- WKN: A2RZHG
- ISIN: XS1961891220
- Land: Australien
Nachricht vom 23.10.2019 | 02:07
Dexus Finance Pty Limited: September 2019 quarter portfolio update
Dexus Finance Pty Limited / Key word(s): Quarter Results/Real Estate
Dexus (ASX: DXS)
23 October 2019
September 2019 quarter portfolio update
Dexus today announced its property portfolio operational update for the quarter ended 30 September 2019.
Darren Steinberg, Dexus Chief Executive Officer said: "This office market cycle is certainly not over, with our office portfolio effectively full and the Sydney and Melbourne office market vacancy rates at very low levels. In this environment we remain confident of being able to continue to drive rental growth in our quality office properties in these markets, particularly in those leases coming up for expiry over the next few years."
Dexus office portfolio
Executive General Manager, Office, Kevin George said: "Our portfolio occupancy remains very high. In a period of limited contiguous space options and limited new supply, we have the opportunity to reset rental levels across 147,900 square metres of vacant or expiring space across our Sydney portfolio, which is currently 8% under-rented, up to the end of FY22. This represents approximately 17% of our total office income.
"We continue to generate good enquiry volumes in line with our experience of the last 18 months and are very encouraged by the growth in SMEs and the technology sector, including cloud computing, social media and cyber security. The services industry generally is still benefiting from significant infrastructure investment in our key markets and this has helped underpin our high occupancy level.
"During the quarter we launched our next stage of office as a service through the acquisition of the Australian operations of Six Ideas, a strategic workplace and change management consultancy, enabling our customers to align their workplace with organisational goals and strategy. We also opened Dexus Place in Perth, which enables us to offer our Perth based and visiting customers the benefits of a state-of-the-art workspace with the flexibility of access from one hour to one month."
Over the quarter to 30 September 2019, a total of 31,927 square metres1 of office space was leased across 77 transactions in the core portfolio and the development projects that are underway or recently completed. Notable activity during the quarter included:
Post 30 September 2019, Dexus and DWPF agreed terms with Herbert Smith Freehills for a long-term lease across 10,300 square metres at the 80 Collins Street precinct South Tower, increasing leased space at the South Tower from 63% to 89%.
Dexus industrial portfolio
Over the quarter to 30 September 2019, 22,691 square metres1 of industrial space was leased across 30 transactions, with notable activity including:
Occupancy (by income) increased slightly to 97.4%, while WALE (by income) was maintained at 4.7 years. Average incentives on leasing undertaken during the quarter reduced compared to FY19, with a higher proportion of deals during the quarter being represented by effective deals. Incentives on face deals were down slightly compared to FY19.
During the quarter, Dexus completed its office development at 240 St Georges Terrace in Perth (now 95% committed with 7.1 year WALE) in addition to the following projects:
Dexus's group development and concept pipeline now stands at a cost of circa $8.7 billion post completions during the quarter, including 240 St Georges Terrace and Calvary Adelaide Hospital.
In early October, Dexus successfully completed the issue of $200 million of domestic Medium Term Notes with a 10-year tenor at an attractive all-in rate of 2.62%.
Dexus's focus on environmental, social and governance (ESG) factors continues to contribute to long-term value, and during the quarter Dexus was recognised by a number of leading global ESG benchmarks, including:
During the quarter, HWPF acquired the North Shore Health Hub, Stage 1 currently under development at 12 Frederick Street, St Leonards. The state-of-the-art healthcare facility, being developed by Dexus, will support existing infrastructure in a growing healthcare precinct on Sydney's lower North Shore and is due for completion in late-2020, with 50% of the facility already pre-committed.
As mentioned in the development section, the new Calvary Adelaide Hospital development was completed during the quarter.
As mentioned above, Dexus sold the North Shore Health Hub on a fund-through basis to HWPF and will continue to manage the development for total revenue of circa $224 million.
The sale is expected to contribute circa $18-22 million in trading profits pre-tax, which will be realised across FY20 and FY21, with the amount for each financial year dependent on the progress of the development and leasing.
Dexus also exchanged contracts to sell a 25% interest in 201 Elizabeth Street, Sydney and entered into a put and call option for the remaining 25% in late 2020 for a total of $315 million. The sale is expected to contribute circa $34 million to pre-tax trading profits in FY20 and is expected to contribute a further circa $34 million in pre-tax trading profits in FY21 in the event either option is exercised.
FY20 outlook and guidance
Darren Steinberg said: "We've seen a significant increase in interest from offshore investors seeking to invest into quality direct office property in our funds management business. This increased interest is partly a function of the relative pricing and rent growth for Australian office comparing favourably to global cities.
"When you combine this trend with the actual transactional evidence that has flowed through in both Sydney and Melbourne over the past few months, along with the spread to bonds which has increased further, we are confident that we will see further cap rate compression.
"Our weighted average office portfolio cap rate was 5.15% at 30 June 2019. We expect circa 25 basis points of cap rate compression to flow through for quality office properties, and at least 25 basis points of cap rate compression for quality industrial properties over the next 12 months.
"Importantly, our high-quality property portfolio with a diversified lease expiry profile and fixed rental increments of 3.5-4.0%, projects in our development and concept pipeline, and our strong balance sheet all place us in a strong position to continue to deliver for investors in a period of continued economic and geopolitical uncertainty."
Dexus reiterates its market guidance for the 12 months ending 30 June 2020 to deliver distribution per security growth of circa 5%, with the distribution payout ratio remaining in line with free cash flow.
 Excluding development leasing.
 Excluding leases which expire in December 2019, 240 St Georges Terrace is 88% committed.
 Global Sector Leader means the entity achieved the highest score for the nature of ownership and sector combined.
 Overall Global Sector Leader means the entity achieved the highest score for its sector, regardless of nature of ownership.
 Land was transferred at fair value. The balance of the proceeds reflects the development spend under a development management agreement that will be paid across a number of fund-through instalments during FY20 and FY21.
 Expected trading profit reflects a potential range of assumptions regarding leasing and incentive outcomes as well as timing of achieving key milestones.
 Barring unforeseen circumstances, guidance is supported by the following assumptions: Impacts of announced divestments and acquisitions; FFO per security growth of circa 3%, underlying FFO per security growth of circa 3%, underpinned by Dexus office portfolio like-for-like income growth of 4.5-5.5%, Dexus industrial portfolio like-for-like income growth (excluding one-offs) of 3-4%, management operations FFO of $55-60 million, cost of debt of mid-3%; trading profits of $35-40 million net of tax; maintenance capex, cash incentives, leasing costs and rent free incentives of $170-185 million; and excluding any further transactions.
For further information please contact:
+61 2 9017 1390
+61 416 122 383
+61 2 9017 1446
+61 403 260 754
Information and Explanation of the Issuer to this News:
Dexus is one of Australia's leading real estate groups, proudly managing a high quality Australian property portfolio valued at $31.8 billion. We believe that the strength and quality of our relationships is central to our success, and are deeply committed to working with our customers to provide spaces that engage and inspire. We invest only in Australia, and directly own $15.6 billion of office and industrial properties. We manage a further $16.2 billion of office, retail, industrial and healthcare properties for third party clients. The group's circa $8.7 billion development and concept pipeline provides the opportunity to grow both portfolios and enhance future returns. With 1.7 million square metres of office workspace across 53 properties, we are Australia's preferred office partner. Dexus is a Top 50 entity by market capitalisation listed on the Australian Securities Exchange (trading code: DXS) and is supported by 26,000 investors from 19 countries. With 35 years of expertise in property investment, development and asset management, we have a proven track record in capital and risk management, providing service excellence to tenants and delivering superior risk-adjusted returns for investors. www.dexus.com
Download the Dexus IR app
|Company:||Dexus Finance Pty Limited|
|264 George Street|
|Phone:||+61 2 9017 1100|
|Fax:||+61 2 9017 1101|
|Listed:||Regulated Unofficial Market in Frankfurt|
|EQS News ID:||894507|
|End of Announcement||DGAP News Service|
Dexus Finance Pty Limited: Appendix 3Y - Chang ...
Dexus Finance Pty Limited: Settlement of first ...
Dexus Finance Pty Limited: Dexus ASX announcements
Dexus Finance Pty Limited: 2019 Annual General ...
Dexus Finance Pty Limited: 2019 Annual General ...
Anleihe im Fokus
"Anleihe - Jetzt zeichnen!"
- Emissionsvolumen: bis zu 100 Mio. EUR
- Zeichnungsfrist: 11.11. bis 04.12.2019
- ISIN: DE000A2YN3Q8 / WKN: A2YN3Q
- Börsenesegment: Börse Frankfurt, Open Market (Quotation Board)
- Stückelung / Emissionspreis: 1.000 EUR/ 100%
- Zinssatz (Kupon): 5,25 %
- Laufzeit: 5 Jahre
- Fälligkeit: 5 Jahre / 6.12.2024 (vorbehaltliche vorzeitige Rückzahlung gemäß Anleihebedingungen)
- Zinszahlung: Angebot an Inhaber der 5,625 % Schuldverschreibung 2016/2021 (WKN A2AA05, ISIN DE000A2AA055) diese in die neue Anleihe zu tauschen
- Umtauschfrist: 11.11.2019 – 29.11.2019 (18.00 Uhr)
Expedeon AG mit attraktiver Produktpipeline
Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.
Der AKTIONÄR News
17. November 16:15 Tesla: 300 Millionen von Steuerzahlern für Giga Berlin?
17. November 09:15 DAX und Co voller Ungewissheit: Kommt nun der Rückschlag? Oder doch ...
17. November 08:15 Global AI Index auf Rekordhoch - so profitieren Anleger vom Megatrend ...
16. November 17:00 Deutsche Rohstoff: Mit 100 Millionen zur Milliarde
16. November 14:08 Amazon, Walt Disney & Co: So geht es weiter
Conference Call zu den Neunmonatszahlen 2019
15. November 2019
Original-Research: Uzin Utz AG (von Montega AG): Kaufen
15. November 2019